Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2020-01-17 | 2020-02-07 | 103569 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2020-01-17 | 2020-04-02 | 103572 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-01-17 | 2020-01-30 | 103578 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-01-17 | 2020-10-22 | 103584 |
| TEVA-RASAGILINE | 0.5MG | TABLET | Resolved | 2020-01-17 | 2020-06-04 | 103587 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-01-17 | 2020-06-18 | 103590 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-01-17 | 2020-02-07 | 103593 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2020-01-24 | 2020-05-14 | 104307 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104319 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104330 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Resolved | 2020-01-24 | 2020-07-10 | 104336 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-01-24 | 2021-03-11 | 104339 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-01-24 | 2021-01-01 | 104344 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104347 |
| TEVA-TIAPROFENIC ACID | 300MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104350 |
| TEVA-FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2020-01-24 | 2020-02-26 | 104353 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-01-24 | 2020-04-09 | 104356 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-01-24 | 2020-02-13 | 104359 |
| TEVA-TOPISONE | .05% | CREAM | Resolved | 2020-01-24 | 2020-02-21 | 104362 |
| TEVA-TOPILENE | 0.5MG | LOTION | Resolved | 2020-01-24 | 2020-04-02 | 104365 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |